Could you by chance run the data in the "Basal Forebrain moderates..." in comparison to the info regarding enhanced methylation of aCh in EDD-sufferers which I posted a few pages back? The study which lead me towards checking out Cholinergic activity among BPD/EDD-ers.
I really can't do that. While the "Basal Forebrain moderates..." paper suggest higher ACh levels are beneficial for humans, the study is based on healthy university (Duke?) students, hardly a cohort representative of BPD and similar problems. On the other hand, the paper on PRIMA-1 methylation suggests too much ACh in BPD, although the evidence is weak. The only other source suggesting some sort of association of ACh with BPD is this: http://www.ncbi.nlm..../pubmed/9326751
It's possible BPD represents too much of the good thing (ACh), but we don't know for sure.
Hmm, yeah it's tricky...
I suppose until there's actually more studies, we won't know for sure. We do know that other mood-disorders, such as Bipolar, fluctuates between too much and too little Serotonin and Dopamine, and Schizophrenics definitely have waaay too much of something that's usually good: dopamine.
So there are certainly precedents among other disorders.
On another note btw...! : D I believe it was finally shown that HydroxyNorKetamine is the metabolite primarily responsible for Ketamine's Antidepressant effects, AND... it's a HIGHLY potent Alpha-7-nicotinic antagonist! When that AD finally comes to market... there might be some real deal dynamite to cannonize those BPD-symptoms, finally!
Oh, and I definitely think there'll be Hydroxynorketamine available in either a group buy or from nootropics-vendors, so we might be able to do some trialling of that soon enough.
EDIT:
Check it out guys! = ) Surprisingly meaty wiki-page actually.
https://en.wikipedia...roxynorketamine
Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptors
http://www.ncbi.nlm....les/PMC3534778/
The results suggest that the inhibitory activity of ketamine metabolites at the α7-nicotinic acetylcholine receptor may contribute to the clinical effect of the drug.
YES!! At last... we have... a gooooooooooooood drug... to pump into the EDD -brain... finally!
Gamesguru.
Are you prepared... to partake in an HNK group buy, and pump yourself full of the possibly most potent antidepressant ever created? And then... stay on this drug, for approximately 3 months?
Jack_Black: you know what you must do - ketamine is the most powerful anti-suicide drug there is - and this is the effective part of the molecule - AND it correlates to my theories regarding EDD pathology.
Your cousin... this could save her. MORE than save her...!
EDIT:
I spoke too soon in my excitement.
HNK's cousin, DHK - Dehydronorketamine, is actually far, far more selective as a potent alpha-7-antagonist. However, it does not show any significant antidepressant effects.
https://en.wikipedia...ydronorketamine
THIS IS GOOD!
Why? Because we want to inhibit response - and since it doesn't make rats try harder to survive a swim-test, then that means it won't perk them up, which means that it may stabilize response more than alter it.
Alas... a drug which inhibits emotional response, and FEAR-response, may not necessarily be as easy to gather a group buy around... Tricky stuff. I look forward to hearing you guys thoughts on the matter though.
Edited by Stinkorninjor, 04 September 2016 - 06:49 PM.